Short description
KayoThera develops therapeutics used to cure late-stage and metastatic cancers.
Description
KayoThera is a biotechnology company developing therapeutics used to cure late-stage and metastatic cancers. Its programs work on inhibiting a key enzyme that is responsible for protecting the cancer cells and depleting regulatory T-cells that intends to cure hitherto incurable cancers and give hope to patients. The company's mission is to develop the first-in-class immuno- and targeted therapies to drive cures in advanced cancers
KayoThera was founded in 2019 and is headquartered in Princeton, New Jersey.
Last funding
Nopepepe
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Princeton, New Jersey, United States, North America
Founded on
January 1, 2019
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$34056 - 789030
Sign in for full access
Investors
Uh Ohhhh, Blurry Noaccess, Noaccess, Noaccess, Noaccessforu, Absolutely Noaccess, Noway Youcantaccess, Noaccessforu
Sign in for full access
Founders
Mark Esposito, Yibin Kang